# SODIUM CARBONATE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid1029621
Categories: cleaning, food, industrial, pharma
Functions: Chelating agent, Chemical reaction regulator, Cleaning agent, Filler, Insulators, Processing aids not otherwise specified, Surfactant (surface active agent), chemical added to raw material by supplier, glass manufacture, pH regulating agent, pulp and paper manufacture, water treatment
Identifier: DTXSID1029621

> SODIUM CARBONATE is used as chelating agent / chemical reaction regulator. EPA CPDat observed this chemical in 2802 composition records across product categories including Construction and building materials, Furniture and furnishings, Cleaning and safety. Assessed from 34 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 2802 composition records across product categories including Construction and building materials, Furniture and furnishings, Cleaning and safety.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 2802 composition records across product categories including Construction and building materials, Furniture and furnishings, Cleaning and safety. EPA CPDat classifies this chemical for functional uses including pH regulating agent, Chelating agent, Cleaning agent.
- US: inactive ingredient database — Route: BUCCAL; Dosage form: GUM, CHEWING; Maximum daily exposure: 720 mg
- US: inactive ingredient database — Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 20 mg
- US: inactive ingredient database — Route: INFILTRATION; Dosage form: INJECTION; Potency: ADJ PH
- US: inactive ingredient database — Route: INTRA-ARTERIAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 32.4 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 630 mg
- US: inactive ingredient database — Route: INTRAVASCULAR; Dosage form: INJECTION; Potency: ADJ PH
- US: inactive ingredient database — Route: INTRAVASCULAR; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 241 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Maximum daily exposure: 1248 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 1247 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.01 %w/v
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 90 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: 6 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 39 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GUM, CHEWING; Maximum daily exposure: 240 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: LOZENGE; Maximum daily exposure: 500 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 48 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Potency: 10.4 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 90 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EFFERVESCENT; Maximum daily exposure: 430 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 80 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 30 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TROCHE; Maximum daily exposure: 375 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: ADJ PH
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 8 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOAP; Potency: 0.5 %w/w
- US: marketed drug occurrence — FDA NDC lists this ingredient in 106 active drug products and 114 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._